MLKMF Waldencast plc
Perfumes, Cosmetics & Other Toilet Preparations · OTC · SEC CIK 1840199
Financial factors as of 2025-12-31 (FY2025), by fiscal year; growth vs the previous fiscal year
Growth
TTM revenue YoY-0.7%
TTM net income YoY-441.3%
TTM EPS YoY-415.4%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—
Margins
Gross margin67.3%
Operating margin-80.0%
Net margin-84.4%
FCF margin-6.0%
EBITDA margin-78.8%
Returns
ROE-40.9%
ROA-26.7%
ROIC (approx.)-24.9%
Asset turnover0.32x
Leverage & solvency
Liabilities / assets33.0%
Debt / equity0.30x
Current ratio1.70x
Interest coverage—
Cash quality & payout
Operating cash flow / net income0.06x
Accruals ratio-25.2%
Payout ratio—
Capex / revenue1.3%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 | FY20232023-12-31 | FY20212021-12-31 | FY20202020-12-31 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | $272.07M | $273.87M | $218.14M | $142.47M | $94.43M |
| Cost of revenue | $89.05M | $82.12M | $76.56M | $55.04M | $29.10M |
| Gross profit | $183.02M | $191.74M | $141.58M | $87.44M | $65.33M |
| R&D expense | — | — | $3.19M | $6.09M | $4.38M |
| SG&A expense | $247.98M | $245.30M | $223.51M | $82.97M | $60.42M |
| Operating income | -$217.54M | -$58.58M | -$81.93M | -$1.62M | $528,000 |
| Interest expense | — | $17.16M | $18.91M | $11.12M | $6.28M |
| Pretax income | -$262.25M | -$48.54M | -$112.94M | -$9.97M | -$5.76M |
| Income tax | -$14.19M | $110,000 | -$6.97M | $9.60M | -$3.39M |
| Net income | -$229.75M | -$42.44M | -$89.98M | -$19.58M | -$2.37M |
| EBITDA | -$214.44M | -$55.28M | -$78.13M | -$1.23M | $528,000 |
| EPS (basic) | -2.01 | -0.39 | -0.99 | -2.45 | -0.30 |
| EPS (diluted) | -2.01 | -0.39 | -0.99 | -2.45 | -0.30 |
| Dividends declared per share | — | — | — | 0.25 | 0.26 |
| Weighted avg. shares (diluted) | 114.07M | 109.30M | 91.16M | 8.00M | 8.00M |
| Balance sheet | |||||
| Cash & equivalents | $30.38M | $14.80M | $21.09M | $13.44M | $8.57M |
| Receivables | — | — | — | $18.74M | — |
| Inventory | $54.61M | $53.10M | $55.68M | $21.61M | — |
| Current assets | $126.94M | $103.62M | $107.33M | $59.04M | $166,792 |
| PP&E, net | $6.24M | $5.83M | $5.93M | $1.20M | — |
| Goodwill | $177.57M | $329.59M | $334.62M | $44.49M | $44.49M |
| Intangibles | $427.10M | $526.44M | $582.86M | $79.57M | — |
| Total assets | $746.16M | $975.86M | $1.04B | $184.59M | $166,792 |
| Current liabilities | $74.55M | $76.89M | $62.71M | $40.80M | $177,743 |
| Short-term debt | $771,000 | $29.48M | $8.53M | $15.44M | — |
| Long-term debt | $135.75M | $137.14M | $151.26M | $103.42M | — |
| Total debt | $136.52M | $166.62M | $159.79M | $118.86M | — |
| Total liabilities | $246.06M | $245.92M | $273.44M | $145.35M | $177,743 |
| Shareholders' equity | $461.88M | $662.32M | $624.63M | $39.24M | -$10,951 |
| Net debt | $106.14M | $151.81M | $138.70M | $105.42M | — |
| Shares outstanding | — | — | — | 8.00M | — |
| Cash flow statement | |||||
| Operating cash flow | -$12.82M | -$8.82M | -$29.77M | $3.53M | -$7.43M |
| Capital expenditure | $3.43M | $2.71M | $1.59M | $424,000 | $1.05M |
| Free cash flow | -$16.25M | -$11.53M | -$31.37M | $3.10M | -$8.48M |
| Investing cash flow | $76.23M | -$2.92M | -$1.99M | -$3.79M | -$1.71M |
| Financing cash flow | -$47.22M | $5.58M | $44.33M | $5.16M | $14.32M |
| Depreciation & amortization | $3.10M | $3.30M | $3.80M | $400,000 | $0 |
| Stock-based compensation | $11.80M | $9.39M | $9.23M | $0 | $0 |
| Dividends paid | — | — | $0 | $2.00M | $2.04M |
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.